Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mihelic R, Kaufman JL, Lonial S. Maintenance therapy in multiple myeloma. Leukemia. 2007;21(6):1150–1157.
Faderl S, Jeha S, Kantarjian HM. The biology and therapy of adult acute lymphoblastic leukemia. Cancer. 2003;98:1337–1354.
Berinstein NL. Principles of maintenance therapy. Leuk Res. 2006;30(Suppl. 1): S3–S10.
Dispenzieri A, Rajkumar SV, Gertz MA, et al. Treatment of newly diagnosed multiple myeloma based on Mayo stratification of myeloma and risk-adapted therapy (mSMART): Consensus statement. Mayo Clin Proc. 2007;82:323–341.
Interferon as therapy for multiple myeloma: An individual patient data overview of 24 randomized trials and 4012 patients. Br J Haematol. 2001;113:1020–1034.
Fritz E, Ludwig H. Interferon-alpha treatment in multiple myeloma: Meta-analysis of 30 randomised trials among 3948 patients. Ann Oncol. 2000;11:1427–1436.
Berenson JR, Crowley JJ, Grogan TM, et al. Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients. Blood. 2002;99: 3163–3168.
Alexanian R, Weber D, Giralt S, Delasalle K. Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy. Ann Oncol. 2002;13:1116–1119.
Stewart AK, Chen CI, Howson-Jan K, et al. Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant. Clin Cancer Res. 2004;10:8170–8176.
Feyler S, Graham J, Rawstron A, EL-Sherbiny Y, Snowden J, Johnson R. Thalidomide maintenance following high dose therapy in multiple myeloma: A UK Myeloma Forum Phase 2 Study. Blood. 2003;102:Abstract #2558.
Feyler S, Rawstron A, Jackson G, Snowden J, Hawkins K, Johnson RJ. Thalidomide maintenance following high dose therapy in multiple myeloma: a UK Myeloma Forum phase 2 study. ASH Annual Meeting Abstracts. Blood. 2003;106:641–691a.
Brinker BT, Waller EK, Leong T, Heffner LT, Redei I, Langston AA, Lonial S. Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma. Cancer. 2006;106:2171–2180.
Attal M, Harousseau JL, Leyvraz S, et al. Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. Blood. 2006;108:3289–3294.
Spencer A, Prince M, Roberts AW, Bradstock KF, Prosser IW. First analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) trial of thalidomide and alternate day prednisolone following autologous stem cell transplantation (ASCT) for patients with multiple myeloma (ALLG MM6). ASH Annual Meeting Abstracts. 2006;108:58–77a.
Spencer AP, Prince M, Roberts AW, Bradstock KF, Prosser IW. Thalidomide improves survival when used following ASCT. Haematologica. 2007;92:41–42.
Peles S, Fisher NM, Devine SM, Tomasson MH, DiPersio JF, Vij R. Bortezomib (Velcade) when given pretransplant and once weekly as consolidation therapy following high dose chemotherapy (HDCT) leads to high rates of reactivation of Varicella Zoster Virus (VZV). ASH Annual Meeting Abstracts. 2005;106:3237–905a.
Schiller GJ, Sohn JP, Malone R, et al. Phase I/II Trial of Bortezomib maintenance following autologous peripheral blood progenitor cell transplantation as treatment for intermediate- and advanced-stage multiple myeloma. ASH Annual Meeting Abstracts. 2006;108:5433–453b.
Knop S, Hebart H, Kunzmann V, Angermund R, Einsele H. Bortezomib once weekly is well tolerated as maintenance therapy after less than a complete response to high-dose melphalan in patients with multiple myeloma. ASH Annual Meeting Abstracts. 2006;108:5099–364b.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kaufman, J.L., Mihelic, R., Lonial, S. (2008). Maintenance Therapy in Multiple Myeloma. In: Lonial, S. (eds) Myeloma Therapy. Contemporary Hematology. Humana Press. https://doi.org/10.1007/978-1-59745-564-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-59745-564-0_7
Publisher Name: Humana Press
Print ISBN: 978-1-934115-82-4
Online ISBN: 978-1-59745-564-0
eBook Packages: MedicineMedicine (R0)